Drug funding for people under 18 with rare bone disorder
CANADA, December 15 - Eligible people in B.C. living with X-linked hypophosphatemia (XLH), a rare genetic and chronically debilitating bone disorder, will have help as the provincial government is covering costs for burosumab, or Crysvita, the medication …